Eloxx Pharmaceuticals Statistics
Total Valuation
ELOX has a market cap or net worth of $60.83 million. The enterprise value is $10.70 million.
| Market Cap | 60.83M |
| Enterprise Value | 10.70M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ELOX has 4.04 million shares outstanding. The number of shares has increased by 1,502.77% in one year.
| Current Share Class | 4.04M |
| Shares Outstanding | 4.04M |
| Shares Change (YoY) | +1,502.77% |
| Shares Change (QoQ) | +54.91% |
| Owned by Insiders (%) | 3.88% |
| Owned by Institutions (%) | 13.68% |
| Float | 931,135 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.25.
| Current Ratio | 3.74 |
| Quick Ratio | 3.65 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -40.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -25.59% |
| Weighted Average Cost of Capital (WACC) | -739,688.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.07M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,369,900.00% in the last 52 weeks. The beta is -160,647.01, so ELOX's price volatility has been lower than the market average.
| Beta (5Y) | -160,647.01 |
| 52-Week Price Change | +1,369,900.00% |
| 50-Day Moving Average | 14.74 |
| 200-Day Moving Average | 4.67 |
| Relative Strength Index (RSI) | 42.93 |
| Average Volume (20 Days) | 49,842 |
Short Selling Information
The latest short interest is 24,447, so 0.61% of the outstanding shares have been sold short.
| Short Interest | 24,447 |
| Short Previous Month | 16,586 |
| Short % of Shares Out | 0.61% |
| Short % of Float | 2.63% |
| Short Ratio (days to cover) | 0.40 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.88M |
| Pretax Income | -10.65M |
| Net Income | -10.65M |
| EBITDA | n/a |
| EBIT | -11.88M |
| Earnings Per Share (EPS) | -$2.84 |
Balance Sheet
The company has $61.96 million in cash and $11.83 million in debt, with a net cash position of $50.13 million or $12.42 per share.
| Cash & Cash Equivalents | 61.96M |
| Total Debt | 11.83M |
| Net Cash | 50.13M |
| Net Cash Per Share | $12.42 |
| Equity (Book Value) | 46.42M |
| Book Value Per Share | 11.50 |
| Working Capital | 46.42M |
Cash Flow
| Operating Cash Flow | -16.02M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 300,000 |
| Free Cash Flow | -16.02M |
| FCF Per Share | -$3.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELOX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,502.77% |
| Shareholder Yield | -1,502.77% |
| Earnings Yield | -17.51% |
| FCF Yield | -26.34% |
Analyst Forecast
The average price target for ELOX is $40.33, which is 167.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.33 |
| Price Target Difference | 167.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2026. It was a reverse split with a ratio of 1:11.
| Last Split Date | Jun 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:11 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |